Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Study Summary

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis.

Conditions

Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Progressive Pulmonary Fibrosis

Interventions / Drugs

Inhaled Treprostinil Treprostinil Ultrasonic Nebulizer

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment1850 participants

Primary Completion—

Lead SponsorUnited Therapeutics

Data Retrieved2026-04-11 04:30:42.432941+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.